| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.1M | +8.2% | +98.4% |
| Cost of Revenue | $3.1M | -2.1% | +75.6% |
| Gross Profit | $9.9M | +11.9% | +106.9% |
| R&D Expense | $4.4M | +6.9% | +10.2% |
| SG&A Expense | $4.9M | +46.8% | +155.8% |
| Operating Income | -$9.0M | -39.0% | -16.2% |
| Interest Expense | $380K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $115.4M | +244.7% | +159.6% |
| Accounts Receivable | $11.3M | +16.3% | — |
| Inventory | $1.3M | +25.5% | — |
| Current Assets | $131.5M | +184.6% | — |
| Total Assets | $134.9M | +153.2% | — |
| Current Liabilities | $10.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.7M | — | — |
| Capital Expenditures | $569K | — | — |
| Investing Cash Flow | -$1.3M | — | — |
| Financing Cash Flow | $100.2M | — | — |
| Free Cash Flow | -$24.2M | — | — |
| +4.7% |
| -5.5% |
| Income Tax | $0 | — | — |
| Net Income | -$8.5M | -26.0% | -9.1% |
| EPS (Basic) | -$0.40 | +72.8% | +80.6% |
| EPS (Diluted) | -$0.40 | +72.8% | +80.6% |
| +15.2% |
| — |
| Long-term Debt | $15.4M | +0.1% | — |
| Total Liabilities | $28.2M | +2.1% | — |
| Stockholders' Equity | $106.7M | +228.4% | +261.5% |